Document Detail


Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).
MedLine Citation:
PMID:  21177352     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare the effect of induction of labour with a policy of expectant monitoring for intrauterine growth restriction near term.
DESIGN: Multicentre randomised equivalence trial (the Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT)).
SETTING: Eight academic and 44 non-academic hospitals in the Netherlands between November 2004 and November 2008.
PARTICIPANTS: Pregnant women who had a singleton pregnancy beyond 36+0 weeks' gestation with suspected intrauterine growth restriction.
INTERVENTIONS: Induction of labour or expectant monitoring.
MAIN OUTCOME MEASURES: The primary outcome was a composite measure of adverse neonatal outcome, defined as death before hospital discharge, five minute Apgar score of less than 7, umbilical artery pH of less than 7.05, or admission to the intensive care unit. Operative delivery (vaginal instrumental delivery or caesarean section) was a secondary outcome. Analysis was by intention to treat, with confidence intervals calculated for the differences in percentages or means.
RESULTS: 321 pregnant women were randomly allocated to induction and 329 to expectant monitoring. Induction group infants were delivered 10 days earlier (mean difference -9.9 days, 95% CI -11.3 to -8.6) and weighed 130 g less (mean difference -130 g, 95% CI -188 g to -71 g) than babies in the expectant monitoring group. A total of 17 (5.3%) infants in the induction group experienced the composite adverse neonatal outcome, compared with 20 (6.1%) in the expectant monitoring group (difference -0.8%, 95% CI -4.3% to 3.2%). Caesarean sections were performed on 45 (14.0%) mothers in the induction group and 45 (13.7%) in the expectant monitoring group (difference 0.3%, 95% CI -5.0% to 5.6%).
CONCLUSIONS: In women with suspected intrauterine growth restriction at term, we found no important differences in adverse outcomes between induction of labour and expectant monitoring. Patients who are keen on non-intervention can safely choose expectant management with intensive maternal and fetal monitoring; however, it is rational to choose induction to prevent possible neonatal morbidity and stillbirth.
TRIAL REGISTRATION: International Standard Randomised Controlled Trial number ISRCTN10363217.
Authors:
K E Boers; S M C Vijgen; D Bijlenga; J A M van der Post; D J Bekedam; A Kwee; P C M van der Salm; M G van Pampus; M E A Spaanderman; K de Boer; J J Duvekot; H A Bremer; T H M Hasaart; F M C Delemarre; K W M Bloemenkamp; C A van Meir; C Willekes; E J Wijnen; M Rijken; S le Cessie; F J M E Roumen; J G Thornton; J M M van Lith; B W J Mol; S A Scherjon;
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-12-21
Journal Detail:
Title:  BMJ (Clinical research ed.)     Volume:  341     ISSN:  1756-1833     ISO Abbreviation:  BMJ     Publication Date:  2010  
Date Detail:
Created Date:  2010-12-23     Completed Date:  2011-01-31     Revised Date:  2012-03-06    
Medline Journal Info:
Nlm Unique ID:  8900488     Medline TA:  BMJ     Country:  England    
Other Details:
Languages:  eng     Pagination:  c7087     Citation Subset:  AIM; IM    
Affiliation:
Leiden University Medical Centre, Leiden, Netherlands. k.e.boers@lumc.nl
Data Bank Information
Bank Name/Acc. No.:
ISRCTN/ISRCTN10363217
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Fetal Growth Retardation / therapy*
Gestational Age
Humans
Labor Onset
Labor, Induced*
Length of Stay
Pregnancy
Pregnancy Outcome
Watchful Waiting*
Young Adult
Investigator
Investigator/Affiliation:
P J A van der Lans / ; G Kleiverda / ; M H B Heres / ; M Wouters / ; A J M Huisjes / ; M J Noordam / ; D N M Papastonis / ; R J P Rijnders / ; W J van Wijngaarden / ; M E van Huizen / ; C J de Groot / ; R H Stigter / ; B M C Akerboom / ; J M Burggraaff / ; A J van Loon / ; P J M Pernet / ; A Lub / ; J G Santema / ; F J A Copraij / ; L S M Ribbert / ; J M J Sporken / ; J W de Leeuw / ; P E van der Moer / ; N van Gemund / ; R Aardenburg / ; C M van Oirschot / ; A P Drogtrop / ; J P R Doornbos / ; A A van Ginkel / ; J van Eyck /
Comments/Corrections
Comment In:
BMJ. 2010;341:c6768   [PMID:  21177350 ]
Evid Based Nurs. 2011 Jul;14(3):85-6   [PMID:  21493640 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Connective tissue fibroblasts and Tcf4 regulate myogenesis.
Next Document:  2, 4-dinitrophenol poisoning caused by non-oral exposure.